CONCIT PHARMA HOLDING ApS Financials, key figures and credit report
Gross profit -31.2 kDKK FY 2023 -13.7% vs 2022
EBIT -31.2 kDKK FY 2023 +97.4% vs 2022
Net debt - 360.9 kDKK FY 2023 +75.7% vs 2022
Quick ratio 9.6 FY 2023 +8 vs 2022
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | - 173.01 | -37.87 | -27.53 | -27.49 | -31.25 |
| Other operating expenses | -1 181.28 | ||||
| EBIT | - 173.01 | -37.87 | -27.53 | -1 208.77 | -31.25 |
| Other financial income | 21.70 | 31.94 | 40.91 | 4.83 | 2.58 |
| Other financial expenses | -1.52 | -12.36 | -33.24 | -49.31 | -3.10 |
| Reduction non-current investment assets | -1 066.45 | 1 066.45 | |||
| Net income from associates (fin.) | - 326.30 | ||||
| Pre-tax profit | - 479.13 | -18.29 | -1 086.32 | - 186.80 | -31.77 |
| Net earnings | - 479.13 | -18.29 | -1 086.32 | - 186.80 | -31.77 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current other receivables | 2 486.85 | 2 477.66 | 1 452.12 | 371.42 | 371.87 |
| Short term receivables total | 2 486.85 | 2 477.66 | 1 452.12 | 371.42 | 371.87 |
| Other current investments | 302.12 | ||||
| Cash and bank deposits | 3 578.12 | 551.18 | 519.36 | 1 484.97 | 58.76 |
| Cash and cash equivalents | 3 578.12 | 551.18 | 519.36 | 1 484.97 | 360.88 |
| Balance sheet total (assets) | 6 064.97 | 3 028.84 | 1 971.47 | 1 856.38 | 732.75 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 306.30 | 306.30 | 306.30 | 306.30 | 306.30 |
| Shares repurchased | 3 000.00 | 1 000.00 | |||
| Retained earnings | 3 152.07 | 1 672.94 | 1 654.65 | 568.33 | 381.54 |
| Profit of the financial year | - 479.13 | -18.29 | -1 086.32 | - 186.80 | -31.77 |
| Shareholders equity total | 5 979.24 | 2 960.95 | 874.63 | 687.84 | 656.07 |
| Non-current liabilities total | |||||
| Other non-interest bearing current liabilities | 85.73 | 67.89 | 1 096.84 | 1 168.55 | 76.68 |
| Current liabilities total | 85.73 | 67.89 | 1 096.84 | 1 168.55 | 76.68 |
| Balance sheet total (liabilities) | 6 064.97 | 3 028.84 | 1 971.47 | 1 856.38 | 732.75 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated